Sentrysciences, Inc.
Longmont, CO Doing business as Sentrysciences LLC Sentrysciences, Inc.
- UEI
- K63NCNGKLCX5
- CAGE
- 9AXE6
- Primary NAICS
- 513210 Software Publishers
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1551 S Sunset St b, Longmont, CO 80501, USA
- Website
- sentrysci.com
- Founded
- 2011
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 50 Wholesale Trade – Durable Goods
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Artificial intelligence and computational statistics platform for biosimilar subvisible characterization | Food and Drug Administration | $55,000 | |
| Aerotrak, 9306-V2, handheld APC, | Medical Command | $16,468 |
About Sentrysciences, Inc.
Sentrysciences, Inc., doing business as Sentrysciences LLC, is a Colorado-based for-profit company that develops artificial intelligence and computational statistics platforms for life-sciences applications, operating as a prime contractor on federal purchase orders with no set-aside designation. The vendor has received three recent federal awards totaling $71 thousand in combined potential value across two prime contracts and one sub-award grant, with activity spanning the Food and Drug Administration, the Defense Health Agency, and the National Institute of Standards and Technology.
Sentrysciences' concrete capability footprint centers on machine-learning platforms for biosimilar drug characterization and medical device analysis. The vendor's largest recent award — a $55 thousand purchase order from FDA issued June 15, 2026, with ultimate completion June 14, 2027 — funds an artificial intelligence and computational statistics platform designed to detect and classify protein aggregates in biosimilar drug products. The platform generates morphological fingerprints of protein aggregates, differentiates particles by stress type and product, and employs neural network-based metric learning to characterize subvisible particles under 100 microns. The system is compatible with Flow Imaging and Backgrounded Membrane Imaging data and includes statistical analysis tools such as Euclidian distance and Kolmogorov-Smirnov test similarity scores; Sentrysciences also provides training for FDA staff on AI/ML application and result interpretation. The vendor's second prime award, a $16.5 thousand purchase order from the Defense Health Agency issued June 29, 2023, supplied AEROTRAK 9306-V2 handheld air particle counters for military health system programs at Fort Sam Houston, Texas. In its sub-award role, Sentrysciences participated in a University of Delaware federal grant focused on evaluation of automated vapor phase hydrogen peroxide decontamination systems for clinical spaces, awarded November 23, 2021.
Customer concentration is thin. FDA and the Defense Health Agency account for all named dollar value across the three-award footprint, with FDA's $55 thousand order representing 77% of combined potential value. One award — the FDA purchase order — faces recompete within the next twenty-four months.
Quick answers
What is Sentrysciences, Inc.'s UEI?
Sentrysciences, Inc.'s Unique Entity ID (UEI) in SAM.gov is K63NCNGKLCX5.
What is Sentrysciences, Inc.'s CAGE code?
Sentrysciences, Inc.'s CAGE code is 9AXE6.
What is Sentrysciences, Inc.'s primary NAICS code?
Sentrysciences, Inc.'s primary NAICS code is 513210 (Software Publishers).
Where is Sentrysciences, Inc. located?
Sentrysciences, Inc.'s physical address in SAM.gov is 1551 S Sunset St b, Longmont, CO 80501, USA.
Is Sentrysciences, Inc. registered in SAM.gov?
Yes. Sentrysciences, Inc.'s SAM.gov registration is active through March 2, 2027.
What is Sentrysciences, Inc.'s most recent federal award?
Sentrysciences, Inc.'s most recent federal contract award is Artificial intelligence and computational statistics platform for biosimilar subvisible characterization (75F40126P00070), from Food and Drug Administration, on June 15, 2026.
On GovTribe
See Sentrysciences, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors